Effect of pirfenidone in patients with more advanced idiopathic pulmonary fibrosis

Data from controlled clinical studies in patients with more advanced idiopathic pulmonary fibrosis (IPF) could inform clinical practice, but they are limited, since this sub-population is usually excluded from clinical trials. These exploratory post-hoc analyses of the open-label, long-term extensio...

Descripción completa

Detalles Bibliográficos
Autores principales: Costabel, Ulrich, Albera, Carlo, Glassberg, Marilyn K., Lancaster, Lisa H., Wuyts, Wim A., Petzinger, Ute, Gilberg, Frank, Kirchgaessler, Klaus-Uwe, Noble, Paul W.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Letter to the Editor
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6416878/
https://www.ncbi.nlm.nih.gov/pubmed/30866942
http://dx.doi.org/10.1186/s12931-019-1021-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6416878/
https://www.ncbi.nlm.nih.gov/pubmed/30866942
http://dx.doi.org/10.1186/s12931-019-1021-2

Ejemplares similares